Literature DB >> 31557024

Validation of the Generalized Force Fields GAFF, CGenFF, OPLS-AA, and PRODRGFF by Testing Against Experimental Osmotic Coefficient Data for Small Drug-Like Molecules.

Shun Zhu1.   

Abstract

Accurate force field parameters for proteins and drugs are of fundamental importance for predicting protein-drug binding poses and binding free energies in structure-based drug design. Osmotic pressure simulations have recently gained popularity as a means to validate common force fields for biomolecules such as proteins; up to now, however, little such effort has been made to use these methods to validate common force fields for small drug-like molecules. In this work, osmotic coefficients of 16 drug-like molecules were calculated from osmotic pressure molecular dynamics simulations using four common force fields for drug-like molecules: GAFF, CGenFF, OPLS-AA, and PRODRGFF. While GAFF, CGenFF, and OPLS-AA produced osmotic coefficients that are in good agreement with the corresponding experimental osmotic coefficients, PRODRGFF, which attempts to use GROMOS parameters, often produced osmotic coefficients that are in poor agreement. All four force fields poorly reproduced the experimental osmotic coefficients of purine-derived molecules including purine, 6-methylpurine, and caffeine, suggesting common issues in describing interactions of this particular molecule type. The poor overall performance of PRODRGFF can be mainly attributed to the poor results with two macrocyclic molecules HMT and TAT, which can be significantly improved by reparameterizing the van der Waals (vdW) parameters of alkyl carbons and using lower solute concentration. In addition, the recently developed GAFF2 with revamped vdW parameters was found to produce osmotic coefficients that are in slightly better agreement with experiments than GAFF. Overall, the four common force fields for drug-like molecules tested in this study performed reasonably well at reproducing experimental osmotic coefficients of drug-like molecules, although failures of certain force fields on certain molecules suggest that further force field reparameterizations, especially for vdW parameters, might be required to improve their accuracy.

Entities:  

Year:  2019        PMID: 31557024     DOI: 10.1021/acs.jcim.9b00552

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  6 in total

1.  In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist.

Authors:  Kristina Puls; Aina-Leonor Olivé-Marti; Szymon Pach; Birgit Pinter; Filippo Erli; Gerhard Wolber; Mariana Spetea
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-28

2.  Atomistic Perspective on Biomolecular Adsorption on Functionalized Carbon Nanomaterials under Ambient Conditions.

Authors:  Marzieh Saeedimasine; Erik G Brandt; Alexander P Lyubartsev
Journal:  J Phys Chem B       Date:  2020-12-29       Impact factor: 2.991

3.  Benchmark assessment of molecular geometries and energies from small molecule force fields.

Authors:  Victoria T Lim; David F Hahn; Gary Tresadern; Christopher I Bayly; David L Mobley
Journal:  F1000Res       Date:  2020-12-03

4.  Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations.

Authors:  Nouman Rasool; Farkhanda Yasmin; Shalini Sahai; Waqar Hussain; Hadiqa Inam; Arooj Arshad
Journal:  Chem Phys Lett       Date:  2021-03-06       Impact factor: 2.328

5.  Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors.

Authors:  Kristina Puls; Helmut Schmidhammer; Gerhard Wolber; Mariana Spetea
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

6.  Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds.

Authors:  Louis K S Darko; Emmanuel Broni; Dominic S Y Amuzu; Michael D Wilson; Christian S Parry; Samuel K Kwofie
Journal:  Biomedicines       Date:  2021-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.